1Venerito M, Kandulski A, Malfertheiner P. Dilemma between gas- troprotection and cardiovascular prevention [ J ]. Dtsch Med Wochenschr,2010,135 (44) :2193 - 2198.
2Small DS, Farid NA, Payne CD, et al. Effects of the proton pump inhibitor lansoprazole on the pharmaeokinetics and pharmacody- namics of prasugrel and clopidogrel [ J ]. J Clin Pharmacol, 2008, 48(4) :475 -484.
3O'Donoghue ML, Braunwald E, Antman EM, et al. Pharrnacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor:an analysis of two randomised trials [ J ]. Lancet,2009.374 ( 9694 ) :989 - 997.
4Siller-Matula JM, Spiel AO, Lang IM, et al. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel [ J ]. Am Heart J ,2009,157 ( 1 ) : 148el - 148e5.
5Sibbing D, Morath T, Steghcrr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel[ J]. Thromb Haemost,2009,101 (4) :714 -719.
6Gaspar A, Ribeiro S, Nabais S, et al. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome [ J ]. Rev Port Cardiol,2010,29 ( 10 ) : 1511 - 1520.
7Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors :a cohort study[ J]. Ann Intern Med,2010,152 (6) :337 - 345.
8Herrickj : Certain Clinical Features of sudden obsteuction of the coronary arferies Trans Am Assort Physicians 1992 ;27 : 100 - 116.
